Tech Company Financing Transactions
BYOMass Funding Round
BYOMass closed a $6.5 million funding round on 3/28/2019. Investors included Juvenescence.
Transaction Overview
Company Name
Announced On
3/28/2019
Transaction Type
Venture Equity
Amount
$6,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
161 Pantry Rd.
Sudbury, MA 01776
USA
Sudbury, MA 01776
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
BYOMass Inc. is a biotechnology company focused on developing therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses. BYOMass was founded by Dr. Margaret Jackson, who has led multiple teams and drug discovery efforts in her twenty-year career as a drug developer. BYOMass is a privately held Massachusetts-based company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Margaret Jackson
Browse more venture capital transactions:
Prev: 3/28/2019: MineralTree venture capital transaction
Next: 3/28/2019: BurnAlong venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs